These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The influence of the human genome on chronic viral hepatitis outcome. de Andrade DR; de Andrade DR Rev Inst Med Trop Sao Paulo; 2004; 46(3):119-26. PubMed ID: 15286811 [TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C. Yee LJ; Im K; Wahed AS; Bugawan T; Li J; Rhodes SL; Erlich H; Rosen HR; Liang TJ; Yang H; Antimicrob Agents Chemother; 2009 Feb; 53(2):615-21. PubMed ID: 18852273 [TBL] [Abstract][Full Text] [Related]
5. Role of genetically determined production of immunoregulatory cytokines in immunopathogenesis of chronic viral hepatitides. Naslednikova IO; Konenkov VI; Ryazantseva NV; Novitskii VV; Tkachenko SB; Zima AP; Avdoshina VV; Beloborodova EI; Beloborodova EV; Dortman VV Bull Exp Biol Med; 2007 Jun; 143(6):706-12. PubMed ID: 18239807 [TBL] [Abstract][Full Text] [Related]
6. Short communication: RNASEL alleles and susceptibility to infection by human retroviruses and hepatitis viruses. Arredondo M; de Bethencourt F; Treviño A; Collado A; Torres P; Barbolla L; Soriano V; de Mendoza C AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1259-61. PubMed ID: 22356654 [TBL] [Abstract][Full Text] [Related]
7. The incidence and significance of pattern-recognition receptors in chronic viral hepatitis types B and C in man. Mozer-Lisewska I; Sikora J; Kowala-Piaskowska A; Kaczmarek M; Dworacki G; Zeromski J Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):295-302. PubMed ID: 20533094 [TBL] [Abstract][Full Text] [Related]
8. Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients. Ezzikouri S; Rebbani K; Mostafa A; El Feydi AE; Afifi R; Brahim I; Kitab B; Benazzouz M; Kandil M; Nadifi S; Pineau P; Benjelloun S J Med Virol; 2011 Dec; 83(12):2096-102. PubMed ID: 22012716 [TBL] [Abstract][Full Text] [Related]
9. [Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection]. Piao WH; He Y; Xi HL; Sun XT; Zhang HH; Xu JH; Zhao H; Xu WX; Li ZL; Wang GQ Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1818-22. PubMed ID: 15631781 [TBL] [Abstract][Full Text] [Related]
10. [Association of immune system gene polymorphisms with quantitative features which are pathogenetically important in chronic viral hepatitis]. Goncharova IA; Beloborodova EV; Freĭdin MB; Beloborodova EI; pyzurev VP Mol Biol (Mosk); 2008; 42(2):242-6. PubMed ID: 18610832 [TBL] [Abstract][Full Text] [Related]
12. [The major histocompatibility complex (MHC) and population genetics]. Satta Y Tanpakushitsu Kakusan Koso; 1994 Nov; 39(15):2599-605. PubMed ID: 7855284 [No Abstract] [Full Text] [Related]
13. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses. Inchauspé G; Michel ML J Viral Hepat; 2007 Nov; 14 Suppl 1():97-103. PubMed ID: 17958650 [TBL] [Abstract][Full Text] [Related]
14. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan. Mah YH; Kao JH; Liu CJ; Chen CL; Chen PJ; Lai MY; Chen DS Liver Int; 2005 Apr; 25(2):214-9. PubMed ID: 15780041 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohort. Henkle E; Lu M; Rupp LB; Boscarino JA; Vijayadeva V; Schmidt MA; Gordon SC; Clin Infect Dis; 2015 Feb; 60(4):514-22. PubMed ID: 25371489 [TBL] [Abstract][Full Text] [Related]